“Efficacy of Brodalumab Vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post Hoc Analysis of Two Phase 3 Psoriasis Studies”. 2021. SKIN The Journal of Cutaneous Medicine 5 (6): s51. https://doi.org/10.25251/skin.5.supp.51.